Hjem › Osteosarkom › Michigan
Osteosarkom kliniske forsøg i Michigan
6 studier for Osteosarkom søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- C S Mott Children's Hospital, Ann Arbor
RekruttererFase 2
Alder 12 til 39 · Alle køn · Opdateret 29. sep. 2026 · NCT04616560Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Hospital of Michigan/Wayne State University, Detroit
RekruttererFase 1/2
Op til 30 år · Alle køn · Opdateret 3. sep. 2026 · NCT06541262Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- C S Mott Children's Hospital, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- og 16 flere
RekruttererFase 3
Op til 50 år · Alle køn · Opdateret 25. aug. 2026 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Ascension Saint John Hospital, Detroit
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 18. maj 2026 · NCT01790152A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
- William Beaumont University Hospital, Royal Oak
Rekrutterer
Alder 13 og opefter · Alle køn · Opdateret 6. feb. 2026 · NCT06387485Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.